Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis

Priya Krishnan, Michael King, Anton W. Neff, George Sandusky, Kristin L. Bierman, Brian Grinnell, Rosamund C. Smith

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A previously identified truncated form of the human Smad 6 gene containing a unique 12 amino acid motif at its N-terminus was studied. We have named this truncated form of the gene Smad 6s, for 'short-form', to distinguish it from the full-length form (Smad 6fl). Reverse transcription-polymerase chain reaction and immunohistochemistry revealed that Smad 6s has a unique pattern of expression in human coronary tissue and is upregulated in diseased heart tissue. We used the expression of human Smad 6s in Xenopus laevis as a model system to assess Smad 6s function. Injection of Smad 6fl RNA (4-cell embryos, 2 × ventral) produced tadpoles with partial secondary axes. In contrast, Smad 6s RNA injected in a similar manner produced tadpoles with a severe 'head-only' phenotype with no morphological appearance of a secondary axis. Mutant Smad 6s RNA lacking the unique 12 amino acids at the N-terminus of the Smad 6s isoform produced no embryonic phenotype, suggesting that this region is important in conferring biological activity. Ectodermal explant assays show that Smad 6s has activity consistent with being a BMP antagonist and can synergize with and enhance the activities of the activin and fibroblast growth factor pathways, all of which are novel findings in this study.

Original languageEnglish
Pages (from-to)115-132
Number of pages18
JournalDevelopment Growth and Differentiation
Volume43
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Xenopus laevis
Larva
Phenotype
Activins
Amino Acid Motifs
Fibroblast Growth Factors
Genes
Reverse Transcription
Heart Diseases
Protein Isoforms
Embryonic Structures
Immunohistochemistry
Head
RNA
Amino Acids
Polymerase Chain Reaction
Injections
6S RNA

Keywords

  • Activin
  • Bone morphogenetic protein
  • Fibroblast growth factor
  • Smad 6
  • Xenopus laevis

ASJC Scopus subject areas

  • Anatomy
  • Developmental Biology
  • Cell Biology

Cite this

Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis. / Krishnan, Priya; King, Michael; Neff, Anton W.; Sandusky, George; Bierman, Kristin L.; Grinnell, Brian; Smith, Rosamund C.

In: Development Growth and Differentiation, Vol. 43, No. 2, 2001, p. 115-132.

Research output: Contribution to journalArticle

Krishnan, Priya ; King, Michael ; Neff, Anton W. ; Sandusky, George ; Bierman, Kristin L. ; Grinnell, Brian ; Smith, Rosamund C. / Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis. In: Development Growth and Differentiation. 2001 ; Vol. 43, No. 2. pp. 115-132.
@article{0dc1c5e776e045a3a3ce8832aa622a86,
title = "Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis",
abstract = "A previously identified truncated form of the human Smad 6 gene containing a unique 12 amino acid motif at its N-terminus was studied. We have named this truncated form of the gene Smad 6s, for 'short-form', to distinguish it from the full-length form (Smad 6fl). Reverse transcription-polymerase chain reaction and immunohistochemistry revealed that Smad 6s has a unique pattern of expression in human coronary tissue and is upregulated in diseased heart tissue. We used the expression of human Smad 6s in Xenopus laevis as a model system to assess Smad 6s function. Injection of Smad 6fl RNA (4-cell embryos, 2 × ventral) produced tadpoles with partial secondary axes. In contrast, Smad 6s RNA injected in a similar manner produced tadpoles with a severe 'head-only' phenotype with no morphological appearance of a secondary axis. Mutant Smad 6s RNA lacking the unique 12 amino acids at the N-terminus of the Smad 6s isoform produced no embryonic phenotype, suggesting that this region is important in conferring biological activity. Ectodermal explant assays show that Smad 6s has activity consistent with being a BMP antagonist and can synergize with and enhance the activities of the activin and fibroblast growth factor pathways, all of which are novel findings in this study.",
keywords = "Activin, Bone morphogenetic protein, Fibroblast growth factor, Smad 6, Xenopus laevis",
author = "Priya Krishnan and Michael King and Neff, {Anton W.} and George Sandusky and Bierman, {Kristin L.} and Brian Grinnell and Smith, {Rosamund C.}",
year = "2001",
doi = "10.1046/j.1440-169X.2001.00562.x",
language = "English",
volume = "43",
pages = "115--132",
journal = "Development Growth and Differentiation",
issn = "0012-1592",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis

AU - Krishnan, Priya

AU - King, Michael

AU - Neff, Anton W.

AU - Sandusky, George

AU - Bierman, Kristin L.

AU - Grinnell, Brian

AU - Smith, Rosamund C.

PY - 2001

Y1 - 2001

N2 - A previously identified truncated form of the human Smad 6 gene containing a unique 12 amino acid motif at its N-terminus was studied. We have named this truncated form of the gene Smad 6s, for 'short-form', to distinguish it from the full-length form (Smad 6fl). Reverse transcription-polymerase chain reaction and immunohistochemistry revealed that Smad 6s has a unique pattern of expression in human coronary tissue and is upregulated in diseased heart tissue. We used the expression of human Smad 6s in Xenopus laevis as a model system to assess Smad 6s function. Injection of Smad 6fl RNA (4-cell embryos, 2 × ventral) produced tadpoles with partial secondary axes. In contrast, Smad 6s RNA injected in a similar manner produced tadpoles with a severe 'head-only' phenotype with no morphological appearance of a secondary axis. Mutant Smad 6s RNA lacking the unique 12 amino acids at the N-terminus of the Smad 6s isoform produced no embryonic phenotype, suggesting that this region is important in conferring biological activity. Ectodermal explant assays show that Smad 6s has activity consistent with being a BMP antagonist and can synergize with and enhance the activities of the activin and fibroblast growth factor pathways, all of which are novel findings in this study.

AB - A previously identified truncated form of the human Smad 6 gene containing a unique 12 amino acid motif at its N-terminus was studied. We have named this truncated form of the gene Smad 6s, for 'short-form', to distinguish it from the full-length form (Smad 6fl). Reverse transcription-polymerase chain reaction and immunohistochemistry revealed that Smad 6s has a unique pattern of expression in human coronary tissue and is upregulated in diseased heart tissue. We used the expression of human Smad 6s in Xenopus laevis as a model system to assess Smad 6s function. Injection of Smad 6fl RNA (4-cell embryos, 2 × ventral) produced tadpoles with partial secondary axes. In contrast, Smad 6s RNA injected in a similar manner produced tadpoles with a severe 'head-only' phenotype with no morphological appearance of a secondary axis. Mutant Smad 6s RNA lacking the unique 12 amino acids at the N-terminus of the Smad 6s isoform produced no embryonic phenotype, suggesting that this region is important in conferring biological activity. Ectodermal explant assays show that Smad 6s has activity consistent with being a BMP antagonist and can synergize with and enhance the activities of the activin and fibroblast growth factor pathways, all of which are novel findings in this study.

KW - Activin

KW - Bone morphogenetic protein

KW - Fibroblast growth factor

KW - Smad 6

KW - Xenopus laevis

UR - http://www.scopus.com/inward/record.url?scp=0035038551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035038551&partnerID=8YFLogxK

U2 - 10.1046/j.1440-169X.2001.00562.x

DO - 10.1046/j.1440-169X.2001.00562.x

M3 - Article

VL - 43

SP - 115

EP - 132

JO - Development Growth and Differentiation

JF - Development Growth and Differentiation

SN - 0012-1592

IS - 2

ER -